Fig. 1
From: Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience
Effects of switching from iron sucrose to iron isomaltoside on different parameters. a Effect on Haemoglobin. b Effect on Ferritin. c Effect on iron dose. d Effect on ESA dose. T0 is the time of change in therapy and represents a mean value of the preceding 6 months. Data are expressed as mean and 95% confidence intervals. Hb, haemoglobin; ESA, erythropoiesis stimulating agent